Published in Cancer Weekly, March 6th, 2007
In this newly-created role, Dr. Benner will lead OncoMed's clinical development efforts, reporting directly to Paul Hastings, OncoMed's President and Chief Executive Officer. Dr. Benner joins OncoMed from PDL BioPharma (formerly known as Protein Design Labs) where he served as Senior Vice President and Chief Medical Officer.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.